Skip to content
Search

Latest Stories

Boots launches ePrescription service for private patients

Boots UK is extending ePrescription service to private patients with the new Doctor Care Anywhere (DCA) digital prescription service.

The service, which is being piloted in 20 Boots stores across central London, gives patients the option to have their prescriptions sent electronically to a Boots Pharmacy within moments of their consultation.


DCA, which provides thousands of online GP consultations each year, will now become the first provider of private ePrescriptions to Boots UK.

“This is a major step towards delivering real change in how the UK’s pharmacy market works for everyone in order to make it a more patient-led experience, enabling people to decide where their prescriptions should be fulfilled in the swiftest and most efficient way. It places power in the hands of patients and it enables pharmacies to manage stock controls more effectively. I believe that this is the best of pharmacy convenience at work,” said Dr Bayju Thakar, Managing Director and Founder.

The new service provides a secure way to transfer prescriptions to the pharmacy as they can only be redeemed once. Patients can keep track of all their prescriptions through their digital patient record with DCA, which can be accessed whenever they need it.

Boots UK already offers an NHS repeat ePrescription service. The company called the new step “a natural step to further increase accessibility and choice for customers.”

Richard Bradley, Pharmacy Director at Boots UK, said: “We know our patients want convenient, simple solutions to manage and take control of their health. This new service makes for a modern pharmacy experience, using digital technology to seamlessly link GP consultations and prescriptions with our pharmacies.”

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less